EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medipal Holdings's enterprise value is 円315,941 Mil.
Medipal Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was 円80,389 Mil. Therefore, Medipal Holdings's EV-to-EBITDA for today is 3.93.
The historical rank and industry rank for Medipal Holdings's EV-to-EBITDA or its related term are showing as below:
TSE:7459'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.37 Med: 5.24 Max: 8.1
Current: 3.94
During the past 13 years, the highest EV-to-EBITDA of Medipal Holdings was 8.10. The lowest was 3.37. And the median was 5.24.
TSE:7459's EV-to-EBITDA is ranked better than 87.65% of 81
companies
in the Medical Distribution industry
Industry Median: 9.9
vs TSE:7459: 3.94
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-25), Medipal Holdings's stock price is 円2433.00.
Medipal Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円175.850. Therefore, Medipal Holdings's PE Ratio for today is 13.84.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Medipal Holdings EV-to-EBITDA Historical Data
The historical data trend for Medipal Holdings's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Medipal Holdings's EV-to-EBITDA
For the Medical Distribution subindustry, Medipal Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medipal Holdings's EV-to-EBITDA Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medipal Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Medipal Holdings's EV-to-EBITDA falls into.
Medipal Holdings EV-to-EBITDA Calculation
Medipal Holdings's EV-to-EBITDA for today is calculated as:
Medipal Holdings's current Enterprise Value is 円315,941 Mil.
Medipal Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円80,389 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Medipal Holdings's PE Ratio for today is calculated as:
Medipal Holdings's share price for today is 円2433.00.
Medipal Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円175.850.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Medipal Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers. The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale. The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives. Medipal Holdings generates the vast majority of its revenue in Japan.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:7459 has been successfully added to your 